mhurhangee/ep-ind-claims huggingface dataset:
An electrical a drive motor of a dental handpiece (80,81,82) for providing a driving force to a cutting tool of the handpiece (80,81,82), the electrical drive motor being connected to the dental handpiece (80,81,82) on its front end side and comprising: a cylindrical casing; a rotor for outputting the driving force, the rotor being rotatably supported inside the casing; a stator provided around the rotor inside the casing; and a first air path (26,27,R) causing cooling air, which is supplied from a rear end side of the electrical drive motor, to pass through an airtight cooling room and to be discharged from the rear end side, such that the cooling air is discharged to the outside without flowing toward the handpiece, the airtight cooling room circumferentially extending between the stator and the casing. a cylindrical casing; a rotor for outputting the driving force, the rotor being rotatably supported inside the casing; a stator provided around the rotor inside the casing; and a first air path (26,27,R) causing cooling air, which is supplied from a rear end side of the electrical drive motor, to pass through an airtight cooling room and to be discharged from the rear end side, such that the cooling air is discharged to the outside without flowing toward the handpiece, the airtight cooling room circumferentially extending between the stator and the casing.
A wearable automated medication delivery system, comprising: a glucose sensor which can be coupled to a user; a controller to receive information from the sensor, the controller to determine a delivery of a medication to a user based on the information from the sensor; and a wearable drug delivery device which can be directly coupled to the user, the wearable drug delivery device to automatically deliver the medication to the user based on an instruction from the controller; characterized by an electronics module which can be removably attached or coupled to the drug delivery device, wherein a wired communication is used for communication between the drug delivery device and the electronics module, and wherein the electronics module provides a wireless communications interface, wherein the module executes an algorithm that computes the times and dosages of delivery of the medication. a glucose sensor which can be coupled to a user; a controller to receive information from the sensor, the controller to determine a delivery of a medication to a user based on the information from the sensor; and a wearable drug delivery device which can be directly coupled to the user, the wearable drug delivery device to automatically deliver the medication to the user based on an instruction from the controller; characterized by an electronics module which can be removably attached or coupled to the drug delivery device, wherein a wired communication is used for communication between the drug delivery device and the electronics module, and wherein the electronics module provides a wireless communications interface, wherein the module executes an algorithm that computes the times and dosages of delivery of the medication.
A semisubmersible floating platform for supporting at least one wind turbine, comprising four buoyant columns; a transition piece having four arms arranged in star configuration and protruding from a central point on which the wind turbine is located in use of the platform, the transition piece being disposed on the buoyant columns at the upper end thereof, the connection between the transition piece and the upper end of the four columns being designed to be located above the sea splash zone; and a heave plate; the semisubmersible floating platform being characterized in that it further comprises a ring pontoon comprising four pontoon portions forming a quadrilateral-shaped ring pontoon, wherein the first lower end of each column is attached to a respective corner of said quadrilateral-shaped ring pontoon, the heave plate being assembled to the internal perimeter of the ring pontoon, the pontoon and heave plate defining a hollow, each of the buoyant columns comprising at least one ballast tank configured for, in use of the platform, allocating sea water in order to adjust the draft and to compensate for the inclination of the platform, said at least one ballast tank comprised in each column being independent of the at least one ballast tank of the other columns.
A heavy duty pneumatic tire comprising a tread that comes into contact with a road surface and a reinforcing layer located inward of the tread in a radial direction, wherein circumferential grooves are formed on the tread, whereby land portions aligned in an axial direction are formed in the tread, among the circumferential grooves, a circumferential groove located on each outer side in the axial direction is a shoulder circumferential groove, a land portion located outward of the shoulder circumferential groove in the axial direction is a shoulder land portion, the reinforcing layer includes a belt including a large number of belt cords aligned with each other, and a band including a band cord, the belt includes a plurality of belt plies aligned in the radial direction, the band includes a full band having ends opposed to each other across an equator plane, and a pair of edge bands located outward of the ends of the full band in the radial direction, and each end of the full band is located outward of the shoulder circumferential groove in the axial direction, characterized in that the heavy duty pneumatic tire has a nominal aspect ratio of 65 % or less, the circumferential grooves are at least three circumferential grooves, the land portions are at least four land portions, the band cord is spirally wound, at least two belt plies (42A, 42B) of the plurality of belt plies are located inward of the full band in the radial direction, and the at least two belt plies (42A, 42B) located inward of the full band have a width larger than a width of the full band. circumferential grooves are formed on the tread, whereby land portions aligned in an axial direction are formed in the tread, among the circumferential grooves, a circumferential groove located on each outer side in the axial direction is a shoulder circumferential groove, a land portion located outward of the shoulder circumferential groove in the axial direction is a shoulder land portion, the reinforcing layer includes a belt including a large number of belt cords aligned with each other, and a band including a band cord, the belt includes a plurality of belt plies aligned in the radial direction, the band includes a full band having ends opposed to each other across an equator plane, and a pair of edge bands located outward of the ends of the full band in the radial direction, and each end of the full band is located outward of the shoulder circumferential groove in the axial direction, characterized in that the heavy duty pneumatic tire has a nominal aspect ratio of 65 % or less, the circumferential grooves are at least three circumferential grooves, the land portions are at least four land portions, the band cord is spirally wound, at least two belt plies (42A, 42B) of the plurality of belt plies are located inward of the full band in the radial direction, and the at least two belt plies (42A, 42B) located inward of the full band have a width larger than a width of the full band.
Electrical device comprising a printed circuit board having conductive tracks, wherein the printed circuit board comprises two similar and/or identical contact surface arrangements, wherein a first of the contact surface arrangements is equipped with a first power module and a second contact surface arrangement is equipped with a second power module, wherein the electrical device comprises - a further printed circuit board comprising further conductive tracks and connection means (10, 14, 16), - and a second plug-in connector part, wherein the second power module is connected in an electrically conductive manner to vias (2, 3, 4) by means of contact surfaces of the second contact surface arrangement and the conductive tracks, wherein the second plug-in connector part is placed on the further printed circuit board and is connected in an electrically conductive manner to the connection means (10, 14, 16) by means of the further conductive tracks, wherein the vias (2, 3, 4) are connected in an electrically conductive manner to the connection means (10, 14, 16) by means of a respective cable (6, 7, 8). - a further printed circuit board comprising further conductive tracks and connection means (10, 14, 16), - and a second plug-in connector part,
Deployable device for allowing access to a vehicle, the said vehicle comprising a housing for stowing the device extending below a vehicle access threshold and having a window allowing the deployment of the device, the said device comprising: - a ramp which is translatable along an axis A between a position in which it is stowed in the housing and a deployed position; and - a flap which is rotatable about an axis B between a protection position in which it closes the window of the housing and a deployed position in which it forms an inclined plane between the ramp and the access threshold; the said device being characterized in that it comprises means (9, 10) for producing a mechanical connection between the ramp and the flap that are designed to move the flap between its protection position and its deployed position during the movement of the ramp between its stowed position and its deployed position and to move the ramp from its stowed position to its deployed position during the movement of the flap from its protection position to its deployed position. - a ramp which is translatable along an axis A between a position in which it is stowed in the housing and a deployed position; and - a flap which is rotatable about an axis B between a protection position in which it closes the window of the housing and a deployed position in which it forms an inclined plane between the ramp and the access threshold;
A compound of formula: or a pharmaceutically acceptable salt thereof, wherein: Y is -C(R 5 R 6)-; R 1 and R 2 are chosen independently from H, aliphatic (C 1 -C 8)hydrocarbon and (C 3 -C 6)cycloalkyl, wherein the aliphatic (C 1 -C 8)hydrocarbon is optionally substituted with one or more of halogen, hydroxyl, (C 1 -C 6)alkoxy, amino, (C 1 -C 6)alkylamino and di(C 1 -C 6)alkylamino; or, taken together, R 1 and R 2 may form (C 3 -C 6)cycloalkyl; R 3 is hydrogen and R 4 is hydrogen or methyl; R 5 and R 6 are both hydrogen; R 9 and R 10 are chosen independently from H, halogen, hydroxyl, (C 1 -C 6)alkyl, (C 1 -C 6)haloalkyl and (C 1 -C 6)alkoxy; R 11, R 12, R 13, and R 14 are chosen independently from H, fluoro, chloro, iodo, cyano, and aliphatic (C 1 -C 8)hydrocarbon, with the proviso that: at least one of R 11, R 12, R 13, and R 14 is other than hydrogen. or a pharmaceutically acceptable salt thereof, wherein: Y is -C(R 5 R 6)-; R 1 and R 2 are chosen independently from H, aliphatic (C 1 -C 8)hydrocarbon and (C 3 -C 6)cycloalkyl, wherein the aliphatic (C 1 -C 8)hydrocarbon is optionally substituted with one or more of halogen, hydroxyl, (C 1 -C 6)alkoxy, amino, (C 1 -C 6)alkylamino and di(C 1 -C 6)alkylamino; or, taken together, R 1 and R 2 may form (C 3 -C 6)cycloalkyl; R 3 is hydrogen and R 4 is hydrogen or methyl; R 5 and R 6 are both hydrogen; R 9 and R 10 are chosen independently from H, halogen, hydroxyl, (C 1 -C 6)alkyl, (C 1 -C 6)haloalkyl and (C 1 -C 6)alkoxy; R 11, R 12, R 13, and R 14 are chosen independently from H, fluoro, chloro, iodo, cyano, and aliphatic (C 1 -C 8)hydrocarbon, with the proviso that: at least one of R 11, R 12, R 13, and R 14 is other than hydrogen. Y is -C(R 5 R 6)-; R 1 and R 2 are chosen independently from H, aliphatic (C 1 -C 8)hydrocarbon and (C 3 -C 6)cycloalkyl, wherein the aliphatic (C 1 -C 8)hydrocarbon is optionally substituted with one or more of halogen, hydroxyl, (C 1 -C 6)alkoxy, amino, (C 1 -C 6)alkylamino and di(C 1 -C 6)alkylamino; or, taken together, R 1 and R 2 may form (C 3 -C 6)cycloalkyl; R 3 is hydrogen and R 4 is hydrogen or methyl; R 5 and R 6 are both hydrogen; R 9 and R 10 are chosen independently from H, halogen, hydroxyl, (C 1 -C 6)alkyl, (C 1 -C 6)haloalkyl and (C 1 -C 6)alkoxy; R 11, R 12, R 13, and R 14 are chosen independently from H, fluoro, chloro, iodo, cyano, and aliphatic (C 1 -C 8)hydrocarbon, with the proviso that: at least one of R 11, R 12, R 13, and R 14 is other than hydrogen.
A method for manufacturing a cross-linkable nitrile rubber composition comprising a carboxyl group-containing highly saturated nitrile rubber obtained by copolymerizing an α,β-ethylenically unsaturated nitrile monomer, an α,β-ethylenically unsaturated dicarboxylic acid monoester monomer, and another copolymerizable monomer, a resin, and a polyamine cross-linking agent, the method comprising: a step of kneading a composition obtained by kneading the carboxyl group-containing highly saturated nitrile rubber and the resin at a temperature equal to or higher than the melting point of the resin with the polyamine cross-linking agent at 10 to 200°C, wherein a content of the carboxyl group-containing highly saturated nitrile rubber is 30 parts by weight or more with respect to 100 parts by weight of a total amount of the carboxyl group-containing highly saturated nitrile rubber and the resin, and the resin is at least one selected from a group consisting of a polyester resin and a polyamide resin. a step of kneading a composition obtained by kneading the carboxyl group-containing highly saturated nitrile rubber and the resin at a temperature equal to or higher than the melting point of the resin with the polyamine cross-linking agent at 10 to 200°C, wherein a content of the carboxyl group-containing highly saturated nitrile rubber is 30 parts by weight or more with respect to 100 parts by weight of a total amount of the carboxyl group-containing highly saturated nitrile rubber and the resin, and the resin is at least one selected from a group consisting of a polyester resin and a polyamide resin.
An expandable hip prosthesis, to be used in patients whose femur head is damaged due to any reason, which can replace the femur head, without any stem and configured in a manner such that it limits the motion within the trochanter; wherein the expandable hip prosthesis comprises: - a grooved shaft, - a lower plate comprising a groove in the hole in the middle in the lower section of said grooved shaft, - an upper plate fixed to the upper section where the grooved section of the grooved shaft is not present, and - a spherical head appropriate to the femur head anatomy, characterised in that the expandable hip prosthesis further comprises: a plurality of sphere slots which are disposed on a lower surface of the upper plate and on an upper surface of the lower plate; a plurality of slot and spherical headed levers and a plurality of spherical headed levers, wherein the plurality of sphere slots positioned on the lower surface of the upper plate are engaged with the plurality of spherical headed levers and the plurality of sphere slots positioned on the upper surface of the lower plate are engaged with the plurality of slot and spherical headed levers, wherein the plurality of spherical headed levers and the plurality of slot and spherical headed levers are engaged with each other at joint sides in a manner such that they can move with respect to each other, and wherein the spherical head is attached to a neck on an upper portion of the grooved shaft. - a grooved shaft, - a lower plate comprising a groove in the hole in the middle in the lower section of said grooved shaft, - an upper plate fixed to the upper section where the grooved section of the grooved shaft is not present, and - a spherical head appropriate to the femur head anatomy, characterised in that the expandable hip prosthesis further comprises: a plurality of sphere slots which are disposed on a lower surface of the upper plate and on an upper surface of the lower plate; a plurality of slot and spherical headed levers and a plurality of spherical headed levers, wherein the plurality of sphere slots positioned on the lower surface of the upper plate are engaged with the plurality of spherical headed levers and the plurality of sphere slots positioned on the upper surface of the lower plate are engaged with the plurality of slot and spherical headed levers, wherein the plurality of spherical headed levers and the plurality of slot and spherical headed levers are engaged with each other at joint sides in a manner such that they can move with respect to each other, and wherein the spherical head is attached to a neck on an upper portion of the grooved shaft.
A double-stranded polynucleotide or a salt thereof, consisting of a polynucleotide represented by the formula and a polynucleotide represented by the formula and having the following features (a) to (d): 5 ⁢ ʹ - X - α - β q - α p - λ m - 3 ⁢ ʹ and 5 ⁢ ʹ - δ s - α - β r - Y - υ n - 3 ⁢ ʹ (a) α and β differently represent a DNA or a 2'-OMeRNA, δ and λ identically or differently represent a DNA or a 2'-OMeRNA, υ identically or differently represents any nucleotide selected from a DNA, an RNA, and a 2'-OMeRNA, and X and Y represent an oligonucleotide consisting of the same or different kinds of nucleotides selected from a DNA, an RNA, and a modified nucleic acid; (b) p represents an integer of 0 or 1, m is 0 when p is 0 and represents any integer from 0 to 5 when p is 1, q represents any integer from 3 to 9, the total number of nucleotides in (α-β) q and X is 17 or 18, s represents an integer of 0 or 1, n represents any integer from 0 to 5, r represents any integer from 3 to 9, and the total number of nucleotides in (α-(β) r and Y is 17 or 18; (c) X- (α-β) q -α p in the polynucleotide represented by the formula has a nucleotide sequence identical to a target gene; and (d) X-(α-β) q in the formula and (α-β) r -Y in the formula have nucleotide sequences complementary to each other. (a) α and β differently represent a DNA or a 2'-OMeRNA, δ and λ identically or differently represent a DNA or a 2'-OMeRNA, υ identically or differently represents any nucleotide selected from a DNA, an RNA, and a 2'-OMeRNA, and X and Y represent an oligonucleotide consisting of the same or different kinds of nucleotides selected from a DNA, an RNA, and a modified nucleic acid; (b) p represents an integer of 0 or 1, m is 0 when p is 0 and represents any integer from 0 to 5 when p is 1, q represents any integer from 3 to 9, the total number of nucleotides in (α-β) q and X is 17 or 18, s represents an integer of 0 or 1, n represents any integer from 0 to 5, r represents any integer from 3 to 9, and the total number of nucleotides in (α-(β) r and Y is 17 or 18; (c) X- (α-β) q -α p in the polynucleotide represented by the formula has a nucleotide sequence identical to a target gene; and (d) X-(α-β) q in the formula and (α-β) r -Y in the formula have nucleotide sequences complementary to each other.
A computer-implemented method for inferencing signal following in a machine learning model, the method comprising: calculating an average standard deviation of measured values of time series signals in a set of more than one time series signal; training the machine learning model to predict values of the signals; predicting values of each of the signals with the trained machine learning model; generating a time series set of residuals between the predicted values and the measured values for each of the signals; calculating an average standard deviation of the sets of residuals; determining that signal following is present in the trained machine learning model where a ratio of the average standard deviation of measured values to the average standard deviation of the sets of residuals exceeds a threshold; and presenting an alert indicating the presence of signal following in the trained machine learning model. calculating an average standard deviation of measured values of time series signals in a set of more than one time series signal; training the machine learning model to predict values of the signals; predicting values of each of the signals with the trained machine learning model; generating a time series set of residuals between the predicted values and the measured values for each of the signals; calculating an average standard deviation of the sets of residuals; determining that signal following is present in the trained machine learning model where a ratio of the average standard deviation of measured values to the average standard deviation of the sets of residuals exceeds a threshold; and presenting an alert indicating the presence of signal following in the trained machine learning model.
A radio frequency, RF, semiconductor device comprising: a semiconductor-on-insulator substrate; an RF ground plane layer on the semiconductor-on-insulator substrate comprising a highly doped semiconductor layer and a conductive superlattice above the highly doped semiconductor layer, the conductive superlattice comprising a plurality of stacked groups of layers (45a-45n), each group of layers comprising a plurality of stacked doped base semiconductor monolayers defining a doped base semiconductor portion (46a-46n), and at least one non-semiconductor monolayer constrained within a crystal lattice of adjacent doped base semiconductor portions; a body above the RF ground plane layer; spaced apart source and drain regions (67, 68) adjacent the body and defining a channel region in the body; and a gate overlying the channel region. a semiconductor-on-insulator substrate; an RF ground plane layer on the semiconductor-on-insulator substrate comprising a highly doped semiconductor layer and a conductive superlattice above the highly doped semiconductor layer, the conductive superlattice comprising a plurality of stacked groups of layers (45a-45n), each group of layers comprising a plurality of stacked doped base semiconductor monolayers defining a doped base semiconductor portion (46a-46n), and at least one non-semiconductor monolayer constrained within a crystal lattice of adjacent doped base semiconductor portions; a body above the RF ground plane layer; spaced apart source and drain regions (67, 68) adjacent the body and defining a channel region in the body; and a gate overlying the channel region.
A method for a cardiovascular risk assessment in a subject comprising the steps of determining in a sample isolated from said subject suffering from chronic kidney disease the presence of polymorphisms, wherein said polymorphisms are at positions 27 within the nucleic acid sequences of SEQ ID NO:1 to 8, wherein the presence at position 27 of a C in SEQ ID NO:1, C in SEQ ID NO:2, T in SEQ ID NO:3, C in SEQ ID NO:4, C in SEQ ID NO:5, A in SEQ ID NO:6, T in SEQ ID NO:7, and G in SEQ ID NO:8, which correspond to db SNP accession number rs17465637, rs6725887, rs9818870, rs12526453, rs1333049, rs501120, rs9982601, rs10455872, respectively, - wherein the polymorphism represented by SEQ ID No 6 can be replaced by the polymorphism represented by SEQ ID No. 49 and/or the polymorphism represented by SEQ ID No.1 can be replaced by the polymorphism represented by SEQ ID No. 48, is indicative of a risk of having a cardiovascular event. - wherein the polymorphism represented by SEQ ID No 6 can be replaced by the polymorphism represented by SEQ ID No. 49 and/or the polymorphism represented by SEQ ID No.1 can be replaced by the polymorphism represented by SEQ ID No. 48, is indicative of a risk of having a cardiovascular event.